3 insiders bought €3.3M of shares over the last 90 days, the latest filed 24 Aug 2026.
Odysight.ai Inc. is a Healthcare & Pharma company. Its directors and officers file their transactions with SEC (Form 4). Over the twelve months to 18 October 2026, 16 filings were filed, from 4 insiders.
On the market, 3 insiders bought (3 purchases totalling €3.3M) while 1 insider sold (12 sales totalling €362k). Purchases outweigh sales by €2.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The largest single trade was a purchase of €3.1M by Arkin Moshe, published on 24 August 2026, equal to 6.7% of the market capitalisation. The buyers include 3 senior executives.
In all, 3 purchases were made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (24 August 2026) now reads 55 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For context, the typical company on the same exchange (median of 5,810 companies) published 19 filings over the same period, against 16 filings here. Over the whole record (from 2025), the tally stands at 3 purchases and 22 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 27 declarations
Odysight.ai Inc. (ticker: ODYS) is a U.S.-listed company on NASDAQ in the United States, focused on AI-enabled visual sensing and predictive maintenance solutions. For investors, the company sits in the “deep tech” segment at the intersection of embedded imaging, condition-based monitoring, and asset reliability analytics for mission-critical environments. Its roots trace back to an Israeli operating business: the company’s Israeli subsidiary was incorporated on January 3, 2019, and the surviving operations of the merged entity became the basis of today’s business at the end of 2019. The company later changed its name to Odysight.ai Inc. in June 2023 and has since expanded its public-market profile through a NASDAQ listing and, more recently, a dual listing in Tel Aviv.
At its core, Odysight.ai develops visual sensing systems that capture data from difficult operating environments and apply AI to detect anomalies, predict failures, and support maintenance decisions before breakdowns occur. Management describes the platform as serving predictive maintenance (PdM) and condition-based monitoring (CBM) use cases, with a primary focus on aerospace, defense, and industrial applications. The company’s solutions are being positioned for aircraft and helicopter monitoring, UAV platforms, defense-related systems, and Industry 4.0 use cases. In practical terms, the value proposition is not only to record images, but to transform visual data into actionable intelligence that can improve uptime, reduce inspection burden, and support safety and readiness.
From a competitive standpoint, Odysight.ai is a niche specialist rather than a broad industrial software platform. That specialization can be an advantage in markets where reliability, certification, and performance in harsh environments matter. Its differentiation lies in a combination of hardware, software, and domain expertise, especially in systems where conventional monitoring tools are less effective. The company also highlights production capabilities in Israel, alongside operational offices in the United States and Europe, which supports commercialization across multiple regions.
Recent company updates point to accelerating commercial traction. For full-year 2025, Odysight.ai reported roughly 23% growth in vision-based PdM/CBM revenues, backlog of about $13.8 million at year-end, and cash of about $26 million with no debt. In 2026, the company announced a commercial collaboration agreement to expand into France’s aerospace, defense, and government aviation markets, and it also announced its dual listing on the Tel Aviv Stock Exchange. In the first quarter of 2026, Odysight.ai reported backlog of about $14 million, cash of about $21.8 million, new pilot orders from a major defense customer, and a Cooperative Research and Development Agreement with the U.S. Naval Air Warfare Center Aircraft Division. Overall, the investment case combines a differentiated technology stack, entry into strategic end markets, and early-stage commercialization momentum, while execution risk remains elevated given the company’s relatively small scale and project-driven revenue profile.
Purchases our model currently ranks for the recommendations list.
All recommendations